Was this page useful?

*Required Field

Research / News & Events/ News





« Back to listings

Researchers at St. Joseph’s Healthcare Hamilton and McMaster University have developed the first widely protective vaccine against chlamydia, a common STI that is mostly asymptomatic but impacts 113 million people around the world each year and can result in infertility.

In a study, recently published in the journal Vaccine, the researchers show that a novel chlamydial antigen known as BD584 is a potential vaccine candidate for the most common species of chlamydia known as Chlamydia trachomatis.

The results look very promising, said senior author James Mahony, a professor of Pathology and Molecular Medicine for McMaster's Michael G. DeGroote School of Medicine and a researcher at St. Joseph's Healthcare Hamilton where the work was performed.

Learn more about this study through CTV, USA Today, BBC, Fox News and The Daily Mail.

Comments are closed.